Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511218 | PMC |
| http://dx.doi.org/10.1186/s12348-021-00270-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Younger Age and Longer Case Times Associated With Emergency Department Visits After Cataract Surgery.
Am J Ophthalmol
January 2023
From the Duke University Medical Center in Durham, North Carolina, USA. Electronic address:
Purpose: To characterize the frequency, reasons, hospital costs, and risk factors for emergency department (ED) visits within 30 days of cataract surgery.
Design: Retrospective cohort study.
Methods: A retrospective review of all cataract surgeries at Duke Health between 2013 and 2021 was conducted.
Rebound iritis with a well-circumscribed anterior chamber fibrin mass after uncomplicated cataract surgery.
J Ophthalmic Inflamm Infect
October 2021
Department of Ophthalmology, Albert Einstein College of Medicine, Montefiore Medical Center, 3332 Rochambeau Ave, 3rd Floor, Bronx, NY, 10467, USA.
Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial.
Drug Deliv Transl Res
January 2022
Singapore National Eye Centre (SNEC), 11 Third Hospital Avenue, Singapore City, 168751, Singapore.
Liposomes as a drug delivery system may overcome the problems associated with non-compliance to eyedrops and inadequate control of inflammation after cataract surgery. We evaluated the safety and efficacy of a single subconjunctival injection of liposomal prednisolone phosphate (LPP) for the treatment of post-cataract surgery inflammation. This is a phase I/II, open-label non-comparative interventional trial of patients undergoing cataract surgery.
View Article and Find Full Text PDFSafety and Efficacy of 0.1% Nepafenac versus 1% Prednisolone Acetate Eye Drops after Laser Peripheral Iridotomy: A Prospective, Randomized Trial.
Ophthalmol Glaucoma
September 2021
Glaucoma Department, Aravind Eye Hospital, Pondicherry, India. Electronic address:
Purpose: To compare 0.1% nepafenac, a topical nonsteroidal anti-inflammatory drop, with 1% prednisolone acetate in controlling inflammation after neodymium:yttrium-aluminum-garnet laser peripheral iridotomy (LPI) in primary angle-closure suspects (PACS).
Design: Randomized controlled trial.
Background: Long-term treatment with antiviral agents has been shown to prevent recurrences of genital and orofacial herpes simplex virus (HSV) disease, but it is uncertain whether prophylactic treatment can prevent recurrences of ocular HSV disease.
Methods: We randomly assigned 703 immunocompetent patients who had had ocular HSV disease within the preceding year to receive 400 mg of acyclovir or placebo orally twice daily. The study outcomes were the rates of development of ocular or nonocular HSV disease during a 12-month treatment period and a 6-month observation period.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!